Data edition of
Residue An evidence-graded reference for peptide science

Peptide list: the compound index

Each compound is graded on the strongest human evidence we could verify, from FDA approval (A) down to cell and animal work only (D). Filter by grade or class, or sort by the size of the record.

Registry and literature counts as of October 19, 2026 · How grades are assigned

A long wooden rack of identical unlabeled glass sample tubes on ruled paper, a closed oxblood notebook at the left
Table 1. Every compound on Residue, by best evidence grade. Bars show PubMed records on a log scale; counts are from the data edition.
Evidence grade
25 compounds
GradeCompoundClassLiteratureRegistered studies
A SemaglutideFDA-approved — Ozempic (2017), Rybelsus (2019), Wegovy (2021) GLP-1 class 5,706 785 · 366 active
A TirzepatideFDA-approved — Mounjaro (2022), Zepbound (2023) GLP-1 class 2,640 300 · 199 active
A ElamipretideFDA accelerated approval — Forzinity (2025) Mitochondrial 470 29 · 3 active
A SermorelinApproved product discontinued (Geref) GHRH & GHRP 366 27 · 1 active
A AfamelanotideFDA-approved (Scenesse implant) · Prescription Melanotan & PT-141 121 23 · 1 active
A BremelanotideFDA-approved (Vyleesi) · Prescription Melanotan & PT-141 113 10 · 1 active
A TesamorelinFDA-approved — Egrifta (2010) GHRH & GHRP 105 24 · 3 active
B LL-37Not FDA-approved · FDA compounding nomination withdrawn Immune 2,412 20 · 2 active
B Thymosin alpha-1Not FDA-approved · FDA compounding nomination withdrawn Immune 622 65 · 19 active
B Kisspeptin-10Not FDA-approved · FDA compounding Category 2 (503A) Neuro & bioregulators 317 36 · 5 active
B RetatrutideInvestigational — not FDA-approved GLP-1 class 207 34 · 11 active
B CagrilintideInvestigational — not FDA-approved GLP-1 class 121 44 · 18 active
C Melanotan IINot FDA-approved · FDA compounding nomination withdrawn Melanotan & PT-141 625 1 · 1 active
C DSIPNot FDA-approved · FDA compounding nomination withdrawn Neuro & bioregulators 463 0
C BPC-157Not FDA-approved · FDA compounding nomination withdrawn Repair 225 4 · 2 active
C SemaxNot FDA-approved · FDA compounding nomination withdrawn Neuro & bioregulators 209 0
C GHK-CuNot FDA-approved · injectable-route nomination withdrawn Repair 134 3 · 2 active
C EpitalonNot FDA-approved · FDA compounding nomination withdrawn Neuro & bioregulators 121 0
C SelankNot FDA-approved · FDA compounding nomination withdrawn Neuro & bioregulators 68 2
C IpamorelinNot FDA-approved · FDA compounding Category 2 (503B) GHRH & GHRP 51 3 · 1 active
C CJC-1295Not FDA-approved · FDA compounding nomination withdrawn GHRH & GHRP 35 1
D TB-500Not FDA-approved · FDA compounding nomination withdrawn Repair 1,157 20 · 3 active
D MOTS-cNot FDA-approved · FDA compounding nomination withdrawn Mitochondrial 264 5 · 4 active
D KPVNot FDA-approved · FDA compounding nomination withdrawn Repair 53 0
D AOD-9604Not FDA-approved · FDA compounding nomination withdrawn GHRH & GHRP 22 0

A–Z of names and aliases

Brand names, development codes and synonyms, each pointing to the monograph that covers the molecule. 101 names for 25 compounds.

A

B

C

D

E

F

G

H

  • hCAP18 (precursor) → LL-37
  • hGH fragment 177-191 analogue → AOD-9604

I

L

M

N

O

P

R

S

T

V

W

Z

By class